Immutep Analyst Price Targets

Wall Street analyst price targets and consensus rating for Immutep (IMMP).

Price Target Range — 3 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingOverweight# Analysts4Avg. Consensus PT$140Upside to Avg. PT+4292.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 17, 2026	Maxim Group	Jason McCarthy	Upgrade	Hold→Buy	—
Mar 13, 2026	Citizens	Reni Benjamin	Downgrade	Market Outperform→Market Perform	—
Mar 13, 2026	Baird	Joel Beatty	Downgrade	Outperform→Neutral	$7→$1
Feb 23, 2026	Citizens	Reni J. Benjamin	Initiate	Market Outperform	$10
Feb 17, 2026	Citizens	Reni J. Benjamin	Initiate	Market Outperform	$6
Nov 15, 2024	Baird	Joel Beatty	PT Raise	Outperform	$6→$7
Jun 27, 2024	Baird	Joel Beatty	PT Cut	Outperform	$7→$6
May 17, 2024	Capital One	Naureen Quibria	Initiate	Overweight	$10

More with Benzinga EdgeGet Access

Analyst Ratings News

This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts changed outlook on top names. See ratings page for upgrades, downgrades, and initiations. Analysts recommend H2O, KRMN, GNSS, WCN, and WM stocks.

Avi Kapoor

This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Wall Street analysts change outlook on top companies. See analyst rating changes and their thoughts on EVCM stock before buying.

Avi Kapoor

PRO
Citizens Downgrades Immutep to Market Perform

Citizens analyst Reni Benjamin downgrades Immutep (NASDAQ:IMMP) from Market Outperform to Market Perform.

Benzinga Newsdesk

PRO
Baird Downgrades Immutep to Neutral, Lowers Price Target to $1

Baird analyst Joel Beatty downgrades Immutep (NASDAQ:IMMP) from Outperform to Neutral and lowers the price target from $7 to $1.

Benzinga Newsdesk

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $10

Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $10.

Benzinga Newsdesk

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

Citizens analyst Reni J. Benjamin initiates coverage on Immutep (NASDAQ:IMMP) with a Market Outperform rating and announces Price Target of $6.

Benzinga Newsdesk

Immutep Ltd

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Immutep Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PRO
Citizens Downgrades Immutep to Market Perform

PRO
Baird Downgrades Immutep to Neutral, Lowers Price Target to $1

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $10

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

People Also Watch

People Also Watch

Immutep Ltd

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Immutep Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

This EverCommerce Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

PROCitizens Downgrades Immutep to Market Perform

PROBaird Downgrades Immutep to Neutral, Lowers Price Target to $1

PROCitizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $10

PROCitizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6

People Also Watch

People Also Watch

PRO
Citizens Downgrades Immutep to Market Perform

PRO
Baird Downgrades Immutep to Neutral, Lowers Price Target to $1

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $10

PRO
Citizens Initiates Coverage On Immutep with Market Outperform Rating, Announces Price Target of $6